Tag Archives: Guido Rasi

No-One's in Charge of Pharmaceuticals in Europe!

Peter O’Donnell’s recent Applied Clinical Trials blog, ‘Who’s in charge of Medicines in Brussels?‘, has been overtaken by history, with the departure of Guido Rasi from his post of Executive Director of the European Medicines Agency. At a time of flux in the European context for pharmaceuticals, Rasi’s moderate manner and capacity for strategic thinking […]
Posted in Europe, Regulatory | Also tagged , | Leave a comment

The European Regulatory Outlook for 2014

Pharm Exec’s EU correspondent, Reflector, looks at some of the European regulatory developments earmarked for 2014 and anticipates their effect on the industry. Personnel Some of the big influences on the pharma industry in Europe next year — and for several years to come — will be the big changes upcoming in key personnel in […]
Posted in Europe, Global, healthcare, R&D, Regulatory | Also tagged , , , , , , , , | Leave a comment

Ethics in Drug Innovation: The First Hurdle is Trust

By Ansis Helmanis Ethics is a matter of trust, which in the regulatory space requires transparency and openness among all stakeholders, including patients and industry.  This was the consensus of FDA Commissioner Margaret Hamburg and European Medicines Agency (EMA) Executive Director Guido Rasi, both of whom shared the podium with Nobel Laureate Professor Elie Wiesel […]
Posted in Europe, Events, FDA, Global, Guest Blog, healthcare, leadership, Market Access, Patient Communication, pricing, Regulatory | Also tagged , , , , , , , | Leave a comment
  • Categories

  • Meta